Lee, Choong-kun http://orcid.org/0000-0001-5151-5096
Rha, Sun Young http://orcid.org/0000-0002-2512-4531
Kim, Hyo Song
Jung, Minkyu
Kang, Beodeul
Che, Jingmin http://orcid.org/0000-0002-2286-6943
Kwon, Woo Sun
Park, Sejung
Bae, Woo Kyun
Koo, Dong-Hoe http://orcid.org/0000-0001-9913-8883
Shin, Su-Jin
Kim, Hyunki http://orcid.org/0000-0003-2292-5584
Jeung, Hei-Cheul
Zang, Dae Young http://orcid.org/0000-0002-2602-7848
Lee, Sang Kil
Nam, Chung Mo
Chung, Hyun Cheol
Article History
Received: 13 January 2022
Accepted: 9 September 2022
First Online: 12 October 2022
Competing interests
: S.Y.R. received grant/research support from MSD, Celltrion, Boehringer-Ingelheim, Eli Lilly, Taiho, Bristol-Myers Squibb, ASLAN, and Incyte; consultation fees for Daiichi Sankyo, MSD, Eli Lilly, Bristol-Myers Squibb, and Eisail; and served on a speaker’s bureau for Eli Lilly, Bristol-Myers Squibb, and MSD outside the submitted work. H.C.C. received grants/research support from Eli Lilly, Glaxo SmithKline, MSD, Merck-Serono, Bristol-Myers Squibb, Taiho, Amgen, Beigene, Incyte, and Zymework; honoraria from Merck-Serono and Eli Lilly; and consultation fees from Taiho, Celltrion, MSD, Eli Lilly, Bristol-Myers Squibb, Merck-Serono, Gloria, Beigene, Amgen, and Zymework outside the submitted work. All remaining authors declare no competing interests.